Successful treatment of Stiff Person Syndrome with intrathecal baclofen
Saul Geffen, Nick Chiang
Rehabilitation Unit, Mater Private Hospital, Australia. E-mail: email@example.com
Preview of fully accepted paper, still not published in any volume
Intrathecal baclofen therapy is a recognized treatment for severe spasticity. We report here a case of stiff person syndrome in Australia, treated with intrathecal baclofen followed by a rehabilitation programme with substantial clinical and functional improvements. A 59-year-old woman diagnosed with stiff person syndrome had become hoist-dependent and required full care due to severe spasticity over the past 12 years. Treatment with oral benzodiazepines and botulinum toxin injections to the affected muscles had no therapeutic response. After a test dose of 100 Âµg intrathecal baclofen resulted in a substantial improvement in her physical function, a decision was made to insert an intrathecal baclofen delivery device. This case report supports the use of intrathecal baclofen therapy and a formal inpatient rehabilitation programme for spasticity related to stiff person syndrome.
Stiff person syndrome, a rare autoimmune and neurological disease that leads to significant disability, can be treated by the use of a device delivering baclofen into the spine combined with physical rehabilitation. A 59-year-old woman was diagnosed with stiff person syndrome and had become dependent, with full-time care, due to severe spasms. Conventional treatment with oral muscle relaxants and botulinum toxin injections to her muscles did not have an adequate effect. A trial dose of baclofen was administered into her spine, followed by implantation of a drug delivery device. This resulted in a substantial improvement in function.
Do you want to comment on this paper? The comments will show up here and if appropriate the comments will also separately be forwarded to the authors.
You need to login/create an account to comment on articles. Click here to login/create an account